Global Immunoassay Market Size, Trends & Growth Opportunity, By Product (Reagents & Kits, Analyzers/Instruments, Software & Services), By Technology (Radioimmunoassay (RIA), Enzyme Immunoassays (EIA), Rapid Test, Others), By Application (Therapeutic Drug Monitoring, Oncology, Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Others), By End-use (Hospitals, Blood Banks, Cl
Report ID : QR1001360 | Industries : Healthcare | Published On :January 2022 | Page Count : 223Global Immunoassay Market
The Global Immunoassay market is projected to grow from USD 28.4 billion in 2020 to USD 39.0 billion by 2026 at a CAGR of over 6.6 % during the forecast period.
An immunoassay is a biochemical test that detects the presence or concentration of a macromolecule or a small molecule in a solution using an antibody or an antigen (sometimes). Multi-step assays are referred to as separation immunoassays and heterogeneous immunoassays. This method is useful for determining oncogenes is and diagnosing cancer, whether benign or malignant, and its various stages. By determining the presence of tumor antigens, it makes it easier to use monoclonal and polyclonal antibodies to detect specific antigens in tissues.
Market Drivers
Increased Incidence of Chronic and Infectious Diseases, as well as Growing Public Awareness of Early Disease Diagnosis
Chronic diseases like diabetes, cardiovascular disease, and cancer are on the rise all over the world. Infectious diseases such as SARS-CoV2 (COVID-19), Dengue, Hepatitis B and C, HIV, Malaria, Tuberculosis, and others are also on the rise. Immunoassay diagnosis has become an important component of these diseases' diagnostic protocols.
Know more about this report: request for sample pages
Market Restraints
Strict Regulatory Requirements for Immunoassay Instrument and Consumable Approval
Several nations' regulatory authorities have drafted stringent regulations for the approval and commercialization of immunoassay consumables and instruments. Furthermore, technological challenges posed by immunoassay kits and reagents such as cross-reactivity of antibodies, low detection limits of available antibodies, false negatives, and others slow the immunoassay market's growth.
Impact of COVID-19
The COVID-19 immunoassay product is critical in containing the virus's spread. In the absence of a vaccine or therapy, the only effective way to control and manage the spread of infections and potential causalities is to diagnose them. Rapid tests have proven to be an effective, quick, and simple molecular test for COVID-19 surveillance on a large scale. Due to extensive research, valuations, and approvals of several immunoassay consumables and analyzers, SARS-CoV2 detection issues have been resolved. The use of immunoassays such as chemiluminescence, enzyme linkeds, lateral flow based point of care tests, rapid tests, and other technologies has increased dramatically.
Market Segmentation
The Global Immunoassay Market is segmented into Product, Application, technology and End-use. By Product such as Integrated Reagents & Kits, Analyzers/Instruments, Software & Services. By Application such as Therapeutic Drug Monitoring, Oncology, Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Others. By End-use such as Hospitals, Blood Banks, Clinical Laboratories, Pharmaceutical and Biotech Companies, Academic Research Centers, Others.
Regional Analysis
Global Immunoassay Market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. During the forecast period, North America is expected to maintain its dominance in the Immunoassay market. This dominance can be attributed to the rising demand for diagnostics as the incidence of cancer rises and technologically advanced diagnostic techniques become more widely available. Furthermore, the region's high prevalence of infectious diseases such as HIV, tuberculosis, and influenza is driving up demand for detection and treatment.
Because of the large geriatric population and high prevalence of infectious diseases in this region, Asia Pacific is the fastest-growing market. In addition, one of the factors driving the market in the region is the growing adoption of innovative laboratory techniques and procedures for faster investigation and diagnosis of infectious and chronic disorders
Key Players
Various key players are listed in this report such as Siemens Healthineers; bioMérieux SA; Abbott Laboratories; Danaher Corporation (Beckman Coulter); Quidel Corporation; Ortho Clinical Diagnostics; Sysmex Corporation; Bio-Rad Laboratories, Inc.; Becton, Dickinson and Company; Thermo Fisher Scientific, Inc.
Market Taxonomy
By Product
- Reagents & Kits
- Analyzers/Instruments
- Software & Services
By Technology
- Radioimmunoassay (RIA)
- Enzyme Immunoassays (EIA)
- Rapid Test
- Others
By Application
- Therapeutic Drug Monitoring
- Oncology
- Cardiology
- Endocrinology
- Infectious Disease Testing
- Autoimmune Diseases
- Others
By End-use
- Hospitals
- Blood Banks
- Clinical Laboratories
- Pharmaceutical and Biotech Companies
- Academic Research Centers
- Others
By Region
- North America
- Latin America
- Europe
- China
- Asia Pacific
- Middle East & Africa
Key Questions Addressed by the Report
- What are the Key Opportunities in Global Immunoassay Market?
- What will be the growth rate from 2020 to 2027?
- Which segment/region will have highest growth?
- What are the factors that will impact/drive the Market?
- What is the competitive Landscape in the Industry?
- What is the role of key players in the value chain?
Global Immunoassay Market TOC
1 Introduction
1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Global Immunoassay Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global Immunoassay Market, By Technology
5.1 Y-o-Y Growth Comparison, By Product
5.2 Global Immunoassay Market Share Analysis, By Product
5.3 Global Immunoassay Market Size and Forecast, By Product
5.3.1 Radioimmunoassay (RIA)
5.3.2 Enzyme Immunoassays (EIA)
5.3.3 Rapid Test
5.3.4 Others
6 Global Immunoassay Market, By Product
6.1 Y-o-Y Growth Comparison, By Product
6.2 Global Immunoassay Market Share Analysis, By Product
6.3 Global Immunoassay Market Size and Forecast, By Product
6.3.1 Reagents & Kits
6.3.2 Analyzers/Instruments
6.3.3 Software & Services
7 Global Immunoassay Market, By Application
7.1 Y-o-Y Growth Comparison, By Application
7.2 Global Immunoassay Market Share Analysis, By Application
7.3 Global Immunoassay Market Size and Forecast, By Application
7.3.1 Therapeutic Drug Monitoring
7.3.2 Oncology
7.3.3 Cardiology
7.3.4 Endocrinology
7.3.5 Infectious Disease Testing
7.3.6 Autoimmune Diseases, Others
8 Global Immunoassay Market, By End-use
8.1 Y-o-Y Growth Comparison, By End-use
8.2 Global Immunoassay Market Share Analysis, By End-use
8.3 Global Immunoassay Market Size and Forecast, By End-use
8.3.1 Hospitals
8.3.2 Blood Banks
8.3.3 Clinical Laboratories
8.3.4 Pharmaceutical and Biotech Companies
8.3.5 Academic Research Centers
8.3.6 Others
9 Global Immunoassay Market, By Region
9.1 Global Immunoassay Market Share Analysis, By Region
9.2 Global Immunoassay Market Share Analysis, By Region
9.3 Global Immunoassay Market Size and Forecast, By Region
10 North America Immunoassay Market Analysis and Forecast (2021-2027)
10.1 Introduction
10.2 North America Immunoassay Market Share Analysis, By Product
10.3 North America Immunoassay Market Size and Forecast, By Application
10.4 North America Immunoassay Market Size and Forecast, By End-use
10.6 North America Immunoassay Market Size and Forecast, By Country
10.7.1 U.S.
10.7.2 Canada
10.7.3 Mexico
11 Europe Immunoassay Market Analysis and Forecast (2021-2027)
11.1 Introduction
11.2 Europe Immunoassay Market Share Analysis, By Product
11.3 Europe Immunoassay Market Size and Forecast, By Application
11.4 Europe Immunoassay Market Size and Forecast, By End-use
11.6 Europe Immunoassay Market Size and Forecast, By Country
11.6.1 Germany
11.6.2 France
11.6.3 UK
11.6.4. Rest of Europe
12 Asia Pacific Immunoassay Market Analysis and Forecast (2021-2027)
12.1 Introduction
12.2 Asia Pacific Immunoassay Market Share Analysis, By Product
12.3 Asia Pacific Immunoassay Market Size and Forecast, By Application
12.4 Asia Pacific Immunoassay Market Size and Forecast, By End-use
12.6 Asia Pacific Immunoassay Market Size and Forecast, By Country
12.6.1 China
12.7.2 Japan
12.8.3 India
12.8.4. Rest of Asia Pacific
13 Latin America Immunoassay Market Analysis and Forecast (2021-2027)
13.1 Introduction
13.2 Latin America Immunoassay Market Share Analysis, By Product
13.3 Latin America Immunoassay Market Size and Forecast, By Application
13.4 Latin America Immunoassay Market Size and Forecast, By End-use
13.6 Latin America Immunoassay Market Size and Forecast, Country
13.7.1. Brazil
13.8.2. Rest of Latin America
14 Middle East Immunoassay Market Analysis and Forecast (2021-2027)
14.1 Introduction
14.2 Middle East Immunoassay Market Share Analysis, By Product
14.3 Middle East Immunoassay Market Size and Forecast, By Application
14.4 Middle East Immunoassay Market Size and Forecast, By End-use
14.6 Middle East Immunoassay Market Size and Forecast, By Country
14.7.1. Saudi Arabia
14.8.2. UAE
14.8.3. Egypt
14.9.4. Kuwait
14.10.5. South Africa
15 Competitive Analysis
15.1 Competition Dashboard
15.2 Market share Analysis of Top Vendors
15.3 Key Development Strategies
16 Company Profiles
16.1 Siemens Healthineers
16.1.1 Overview
16.1.2 Products
16.1.3 Key Financials
16.1.4 Business Segment & Geographic Overview
16.1.5 Key Market Developments
16.1.6 Key Strategies
17.2. bioMérieux SA
17.2.1 Overview
17.2.2 Products
17.2.3 Key Financials
17.2.4 Business Segment & Geographic Overview
17.2.5 Key Market Developments
17.2.6 Key Strategies
18.3. Abbott Laboratories
18.3.1 Overview
18.3.2 Products
18.3.3 Key Financials
18.3.4 Business Segment & Geographic Overview
18.3.5 Key Market Developments
18.3.6 Key Strategies
19.4 Danaher Corporation
19.4.1 Overview
19.4.2 Products
19.4.3 Key Financials
19.4.4 Business Segment & Geographic Overview
19.4.5 Key Market Developments
19.4.6 Key Strategies
20.5 Quidel Corporation
20.5.1 Overview
20.5.2 Products
20.5.3 Key Financials
20.5.4 Business Segment & Geographic Overview
20.5.5 Key Market Developments
20.5.6 Key Strategies
21.6 Ortho Clinical Diagnostics
21.6.1 Overview
21.6.2 Products
21.6.3 Key Financials
21.6.4 Business Segment & Geographic Overview
21.6.5 Key Market Developments
21.6.6 Key Strategies
22.7 Sysmex Corporation
22.7.1 Overview
22.7.2 Products
22.7.3 Key Financials
22.7.4 Business Segment & Geographic Overview
22.7.5 Key Market Developments
22.7.6 Key Strategies
23.8 Bio-Rad Laboratories, Inc
23.8.1 Overview
23.8.2 Products
23.8.3 Key Financials
23.8.4 Business Segment & Geographic Overview
23.8.5 Key Market Developments
23.8.6 Key Strategies
24.9 Becton, Dickinson and Company
24.9.1 Overview
24.9.2 Products
24.9.3 Key Financials
24.9.4 Business Segment & Geographic Overview
24.9.5 Key Market Developments
24.9.6 Key Strategies
25.10 Thermo Fisher Scientific, Inc
25.10.1 Overview
25.10.2 Products
25.10.3 Key Financials
25.10.4 Business Segment & Geographic Overview
25.10.5 Key Market Developments
25.10.6 Key Strategies